Nathaniel W. Mabe

Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1

Nathaniel W. Mabe, Min Huang, Guillermo Nicolás Dalton et al. · Nature Cancer · 2022 · 100 citations · Full text

Neuro-oncology, Glioma, Neuroblastoma Confers +6

Regulator of G Protein Signaling 6 Protects the Heart from Ischemic Injury

Boyd R. Rorabaugh, Bandana Chakravarti, Nathaniel W. Mabe et al. · Journal of Pharmacology and Experimental Therapeutics · 2016 · 58 citations · Full text

VRK1 as a synthetic lethal target in VRK2 promoter–methylated cancers of the nervous system

Jonathan So, Nathaniel W. Mabe, Bernhard Englinger et al. · JCI Insight · 2022 · 56 citations · Full text

Dna Methylation, Cell Death, Collateral Lethality +16

RIPK3 upregulation confers robust proliferation and collateral cystine-dependence on breast cancer recurrence

Chao‐Chieh Lin, Nathaniel W. Mabe, Yi-Tzu Lin et al. · Cell Death and Differentiation · 2020 · 55 citations · Full text

Breast Cancer Recurrence, Oncology, Breast Oncology +9

Epigenetic silencing of tumor suppressor Par-4 promotes chemoresistance in recurrent breast cancer

Nathaniel W. Mabe, Douglas B. Fox, Ryan Lupo et al. · Journal of Clinical Investigation · 2018 · 51 citations · Full text

Epigenetic Silencing, Breast Cancer Recurrence, Breast Oncology +14